Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TZD vs DPP-4 inhibitor as add-on to metformin + SGLT2 inhibitor in type 2 diabetes
KCT0010143Phase 4Not yet recruiting
- Sponsor
- Boryung
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Boryung. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on KCT0010143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010143.